Ro antibody

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Synonym(s)

SS-A antibodies; SSA antibody

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Heterogeneous antibody complex consisting of autoantibodies against a 52 and 60 kDa nuclear protein.

General informationThis section has been translated automatically.

Anti-Ro/SSA is considered a relatively specific autoantibody for various autoimmune diseases, especially:

HLA-DR3 is associated with anti-Ro and anti-La antibodies.

Patients with C2 and C4 deficiencies tend to produce anti-Ro/SSA antibodies without detection of anti-La/SSB antibodies.

Anti-Ro/SSA antibodies are found irregularly in the following diseases:

  • polymositis/dermatomyositis
  • Non-erosive arthropathy (Jaccoud arthropathy)
  • Late-Onset-SLE
  • Neonatal lupus erythematosus.

OccurrenceThis section has been translated automatically.

Detection in 30-40% of cases of systemic lupus erythematosus and 60-70% of cases of Sjögren's syndrome. RO-antibodies are particularly important in neonatal lupus erythematosus in combination with a congenital heart block caused by expression of the FSA antigen in the excitation conduction system. In 70-80% of patients with subacute cutaneous lupus erythematosus, Ro/SS-A antibodies are detectable and simultaneously associated with increased light sensitivity. UV exposure leads to induction of SS-A on keratinocytes.

Note(s)This section has been translated automatically.

RO = Patient initials

LiteratureThis section has been translated automatically.

  1. Arbuckle MR et al (2003) Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 349: 1526-1533
  2. Franceschini F et al (2005) Anti-Ro/SSA and La/SSB abtibodies. Autoimmunity 38: 55-63
  3. Furukawa F et al (1990) Binding of antibodies to the extractable nuclear antigens SS-A/Ro and SS-B/La is induced on the surface of human keratinocytes by ultraviolet light (UVL): implications for the pathogenesis of photosensitive cutaneous lupus. J Invest Dermatol 94: 77-85
  4. Ho KT et al (2003) The clinical relevance of autoantibodies in scleroderma. Arthritis Res Ther 5: 80-93
  5. Popovic K et al (2006) Fine specifity of the Ro/SSa antoantibody response in relation to serological and clinical findings in 96 patients with self-reported cutaneous symptoms induced by the sun. Lupus 16: 10-17

Authors

Last updated on: 29.10.2020